PPARG and ovarian carcinoma: Thus, the present results suggested that ligand-mediated PPARγ activation suppressed COX-2 expression via the NFκB pathway in the ovarian carcinoma cells, and that high expression of PPARγ and low expression of COX-2 might play an important role in inhibiting ovarian carcinogenesis.